Analyses of the fecal microbiota diversity in and among the PROBIOTA-Bb fecal samples (Fig. S1); analyses of enterotypes in samples of the PROBIOTA-Bb trial (Fig. S2); Tukey box plots representing the bacterial taxonomic richness of enterotypes assessed with a Chao1 estimator of α-diversity (Fig. S3); bacterial taxa that were significantly modified by probiotic or placebo treatment (Table S1); bacterial taxa that were significantly modified in terms of enterotypes by probiotic or placebo treatment (Table S2); levels of short-chain fatty acids (SCFA) in the fecal samples (Table S3); effects of the probiotic and placebo treatments on fecal short-chain fatty acid concentration (Table S4); bacterial taxa that were significantly modified in terms of SCFA groups by probiotic or placebo treatment (Table S5).
PDF, 1.0M